Retention of cocaine abusers in outpatient psychotherapy. 1992

P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
Department of Public Health, Cornell University Medical College, New York, New York 10001.

Retention in outpatient psychotherapy of 148 crack and cocaine abusers was examined. The clients were predominantly Black (63%) and Hispanic (21%), predominantly male (87%), and the majority (66%) had completed no more than 12 years of high school. Clients entered treatment in a low-cost treatment center in New York City between June 1987 and November 1988. Forty-two percent (62) of the subjects were seen for one or two research interviews only, and did not return to begin therapy. Of the 86 persons who came to at least one therapy session, 30% (26) dropped out before the third session, 28% (24) dropped out between the third and fifth sessions, and 42% (36) were retained for six or more sessions. Short-term and longer-term retentions were analyzed separately, using a battery including sociodemographic variables, treatment history, psychiatric symptomatology, number of arrests, and drug use variables. None of the variables considered was significantly related to short-term retention. There were large although not significant differences in longer term retention by therapist. Longer-term retention was associated significantly with being White (contrasted with being Black) and being young. Nonsignificant but large associations were found between longer-term retention and having few arrests, being Hispanic (contrasted with being Black), and having low SCL-90 scores. Results are compared with previous findings about retention in drug and alcohol treatment. It is suggested that future research on retention in treatment focus less on client variables and more on therapist and program variables.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009519 New York City City located at the mouth of the Hudson River, in New York State.
D010352 Patient Dropouts Discontinuance of care received by patient(s) due to reasons other than full recovery from the disease. Dropout, Patient,Dropouts, Patient,Patient Dropout
D011613 Psychotherapy A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication. Psychotherapies
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
January 1985, The American journal of drug and alcohol abuse,
P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
March 1994, Archives of general psychiatry,
P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
May 1998, Experimental and clinical psychopharmacology,
P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
May 1997, Experimental and clinical psychopharmacology,
P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
January 1988, Journal of substance abuse treatment,
P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
January 2001, Journal of substance abuse treatment,
P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
January 1997, Journal of addictive diseases,
P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
April 1995, The Journal of nervous and mental disease,
P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
August 1995, The American journal of drug and alcohol abuse,
P H Kleinman, and S Y Kang, and D S Lipton, and G E Woody, and J Kemp, and R B Millman
August 2003, Drug and alcohol dependence,
Copied contents to your clipboard!